Skip Navigation



Rheumatology Advance Access published online on September 20, 2005
Rheumatology, doi:10.1093/rheumatology/kei106
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary data
Right arrow All Versions of this Article:
45/1/76    most recent
kei106v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Foeldvari, I.
Right arrow Articles by Wierk, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Foeldvari, I.
Right arrow Articles by Wierk, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Received March 6, 2005
Accepted August 9, 2005

Original Papers

Healthy children have a significantly increased skin score assessed with the modified Rodnan skin score

I. Foeldvari 1* and A. Wierk 1

1 Pediatric Rheumatologic Clinic, Allgemeines Krankenhaus Eilbek, Hamburg, Germany

* To whom correspondence should be addressed.
I. Foeldvari, E-mail: Sprechstunde{at}kinderrheumatologie.de


  Abstract

Objectives. The modified Rodnan skin score (MRSS) is used as a primary outcome measure in most therapeutic trials in systemic sclerosis (SSc) in adults. Before we can apply this outcome measure in trials in juvenile patients with SSc, we need to evaluate this assessment method in children without sclerodermatous skin changes, to establish values for the normal paediatric population.

Methods. To determine the MRSS in healthy paediatric population, patients of the paediatric rheumatology out-patient clinic with mechanical pain or with juvenile idiopathic arthritis at the age of 16 yr or under were assessed between 1 January and 31 March 2004. Patients with any sign of connective tissue disease or skin disorders, such as psoriasis or ectopic dermatitis, were excluded. The MRSS was determined at a standardized location and with a standardized pinching method.

Results. Two hundred and seventeen patients, including 100 females, were assessed. The mean age of the patients was 10.5 yr (2.9-16), the mean body mass index (BMI) was 18.3 (9.3-35.7), and the mean MRSS was 13.92 (range 4-25). The MRSS score showed a difference between males and females at every Tanner stage. There was a linear correlation between MRSS and body mass index independently of age and Tanner stage.

Conclusion. The mean MRSS in healthy children is 13.92 units and this range would be expected in a patient with a diffuse form of SSc. The MRSS score in children correlates with the body mass index and the Tanner stage, so it should be corrected to these parameters, according to this pilot study.

Keywords: Modified Rodnan skin score; Children; Juvenile systemic sclerosis; Systemic sclerosis.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
G. Martini, F. Vittadello, O. Kasapcopur, S. Magni Manzoni, F. Corona, C. Duarte-Salazar, D. Nemcova, C. A. Len, S. M. Garay, S. Ullman, et al.
Factors affecting survival in juvenile systemic sclerosis
Rheumatology, February 1, 2009; 48(2): 119 - 122.
[Abstract] [Full Text] [PDF]

Home page
 AAP Grand RoundsHome page
S. C. Li
Juvenile Systemic Sclerosis: Still a Serious Disease
AAP Grand Rounds, April 1, 2007; 17(4): 45 - 46.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
I. Foeldvari
Systemic sclerosis in childhood
Rheumatology, October 1, 2006; 45(suppl_3): iii28 - iii29.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.